Katsuyuki Hotta

  • 5449 Citations
  • 29 h-Index
19982019
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 42 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
Cisplatin Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
irinotecan Medicine & Life Sciences
Survival Medicine & Life Sciences
Small Cell Lung Carcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2019

  • 5449 Citations
  • 29 h-Index
  • 200 Article
  • 3 Review article
  • 1 Comment/debate
  • 1 Letter

A phase I/II trial of weekly nab-paclitaxel for pretreated non-small-cell lung cancer patients without epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangement

Harada, D., Kozuki, T., Nogami, N., Bessho, A., Hosokawa, S., Fukamatsu, N., Hotta, K., Oohashi, K., Kubo, T., Yoshioka, H., Yokoyama, T., Sone, N., Kuyama, S., Kudo, K., Yasugi, M., Takigawa, N., Oze, I. & Kiura, K., Jan 1 2019, In : Asia-Pacific Journal of Clinical Oncology.

Research output: Contribution to journalArticle

Open Access
Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Mutation
Nanoparticles
Appointments and Schedules

Corrigendum to “Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer: A phase 1b and randomized, open-label, multicenter, phase 2 trial in Japan” [Lung Cancer, 129 (March) (2019) 55–62](S0169500219300212)(10.1016/j.lungcan.2019.01.005)

Watanabe, S., Yoshioka, H., Sakai, H., Hotta, K., Takenoyama, M., Yamada, K., Sugawara, S., Takiguchi, Y., Hosomi, Y., Tomii, K., Niho, S., Yamamoto, N., Nishio, M., Ohe, Y., Kato, T., Takahashi, T., Kamada, A., Suzukawa, K., Omori, Y., Enatsu, S. & 2 othersNakagawa, K. & Tamura, T., Jan 1 2019, In : Lung Cancer.

Research output: Contribution to journalComment/debate

Open Access
gemcitabine
Non-Small Cell Lung Carcinoma
Cisplatin
Lung Neoplasms
Japan

Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer: A phase 1b and randomized, open-label, multicenter, phase 2 trial in Japan

Watanabe, S., Yoshioka, H., Sakai, H., Hotta, K., Takenoyama, M., Yamada, K., Sugawara, S., Takiguchi, Y., Hosomi, Y., Tomii, K., Niho, S., Yamamoto, N., Nishio, M., Ohe, Y., Kato, T., Takahashi, T., Kamada, A., Suzukawa, K., Omori, Y., Enatsu, S. & 2 othersNakagawa, K. & Tamura, T., Mar 1 2019, In : Lung Cancer. 129, p. 55-62 8 p.

Research output: Contribution to journalArticle

gemcitabine
Non-Small Cell Lung Carcinoma
Cisplatin
Japan
Therapeutics

Physician requests by patients with malignant pleural mesothelioma in Japan

Nagamatsu, Y., Oze, I., Aoe, K., Hotta, K., Kato, K., Nakagawa, J., Hara, K., Kishimoto, T. & Fujimoto, N., Apr 25 2019, In : BMC cancer. 19, 1, 383.

Research output: Contribution to journalArticle

Open Access
Japan
Physicians
Malignant Mesothelioma
Communication
Asbestos

Rapid and Long-term Response of Pulmonary Pleomorphic Carcinoma to Nivolumab

Senoo, S., Ninomiya, T., Makimoto, G., Nishii, K., Kano, H., Watanabe, H., Hata, Y., Kubo, T., Tanaka, T., Hotta, K., Maeda, Y. & Kiura, K., Apr 1 2019, In : Internal medicine (Tokyo, Japan). 58, 7, p. 985-989 5 p.

Research output: Contribution to journalArticle

Open Access
Cell Death
Carcinoma
Lung
Neoplasms
Macrophages